Sealand Capital Galaxy Limited Statement re Share Price Movement

RNS Number : 2927S

Sealand Capital Galaxy Limited

06 January 2025

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

06 January 2025

 

 

Sealand Capital Galaxy Limited

("Sealand" or the "Company")

 

 

 Statement regarding share price movement

 

Sealand Capital Galaxy Limited [LSE: SCGL] ("Sealand" or the "Company"), an IT, Social Media & Technology company focused on consolidating compelling opportunities in the global marketplace makes the following announcement.

 

The board of directors has noted the recent rise in the Company's share price and confirms that it knows of no reason for this increase.

 

The Company wishes to draw attention to the announcement made on 22 November 2024 relating to a conditional investment in EVOO AI plc. Following the holiday break, due diligence continues to progress and the Company are hopeful to update the market as to a decision in the near term.

 

-Ends-

 

Enquiries:

 

Sealand Capital Galaxy Limited                                                       [phone]

Ms. Elena Suet Sum Law (Executive Chairman & CEO)                   

 

Bowsprit Partners Limited (Financial Adviser)                              [phone]

 

Notes to Editors:

The Company's shares are traded on the transition category of the London Stock Exchange under the ticker SCGL.

Further information on Sealand Capital Galaxy Limited is available on its website http://www.scg-ltd.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

SPMUPUUPGUPAGAQ